Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
2,614
Views
4
CrossRef citations to date
0
Altmetric
Immunotherapy – Commentary

Future prospects for cancer immunotherapy - Strategies for ineffective cancers

Satoshi Wadaa Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan;b Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan;c Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6528-5914View further author information
ORCID Icon,
Shinichi Kobayashib Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, JapanView further author information
&
Takuya Tsunodac Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, JapanView further author information
Article: 2031699 | Received 29 Dec 2021, Accepted 18 Jan 2022, Published online: 25 Jan 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhiwei Zheng, Ling Fang, Hongfu Cai & Huide Zhu. (2023) Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China. Expert Review of Pharmacoeconomics & Outcomes Research 23:6, pages 683-690.
Read now

Articles from other publishers (3)

Jie-ping Wang, Meng-yu Zhang, Ming Luo, Shu Qin & Xian-ming Xia. (2022) Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Scientific Reports 12:1.
Crossref
Wang Yaping, Wang Zhe, Chu Zhuling, Li Ruolei, Fan Pengyu, Guo Lili, Ji Cheng, Zhang Bo, Liu Liuyin, Hou Guangdong, Wang Yaoling, Hou Niuniu & Ling Rui. (2022) The soldiers needed to be awakened: Tumor-infiltrating immune cells. Frontiers in Genetics 13.
Crossref
Panagiotis Parsonidis & Ioannis Papasotiriou. (2022) Adoptive Cellular Transfer Immunotherapies for Cancer. Cancer Treatment and Research Communications 32, pages 100575.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.